LINC02362 was also revealed to sponge miR‐18a‐5p and promote expression of its downstream target FDX1—a key regulator in cuproptosis and upstream regulator of protein lipoylation, which expression levels are associated with improved survival of HCC patients. The gene discussed is LINC02362; the disease is hepatocellular carcinoma.